Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Molecular Characterization of Residual Bladder Cancer After Neoadjuvant PembrolizumabEur Urol 2021 Mar 27;[EPub Ahead of Print], A Necchi, JJ de Jong, D Raggi, A Briganti, L Marandino, A Gallina, M Bandini, B Dabbas, E Davicioni, U Capitanio, F Montorsi, R Seiler, JL Wright, Y Lotan, PC Black, EA Gibb
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.